MMV652103, the diaryl imidazole pyridazine compound MMV652103 inhibits the oncogenic PI4KB and PIK3C2G lipid kinases, is selectively cytotoxic, and inhibits survival and migration in T47D estrogen receptor-positive BC cells. This evidence concerns the gene ESR1 and breast cancer.